| Denner Alexander JDirector · 44 transactions | — | 658.1K†as of Jun 2022 | 64.9K | 643.0K | 48.9K |
| Sharp Philip ADirector · 78 transactions | — | 470.3Kas of Jun 2009 | 180.3K | — | 172.5K |
| Mullen James CCEO & President, Director · 252 transactions | — | 184.3K†as of Jun 2010 | 2.11M | — | 1.85M |
| Matsui ConnieEVP, Corp. Strategy and Comm. · 56 transactions | — | 116.7K†as of Feb 2007 | 306.0K | — | 318.6K |
| Pickett Cecil BPresident, R & D, Director · 17 transactions | — | 101.3Kas of Oct 2009 | 221.4K | — | 54.3K |
| Vounatsos MichelChief Executive Officer, Director · 39 transactions | — | 70.0Kas of Feb 2022 | 97.4K | 11.0K | — |
| Scangos George AChief Executive Officer, Director · 116 transactions | — | 60.2K†as of Jul 2016 | 292.5K | — | 117.3K |
| Alexander Susan HEVP Chief Legal Officer · 179 transactions | — | 58.5K† | 348.8K | — | 209.3K |
| Hasler Hans PeterChief Operating Officer · 94 transactions | — | 53.3Kas of Feb 2009 | 291.3K | — | 244.3K |
| Belzer AlanDirector · 15 transactions | — | 53.0K†as of May 2007 | 70.3K | — | 69.0K |
| Hasnain FaheemEVP, Oncology/Rheumatology SBU · 50 transactions | — | 52.6Kas of Jul 2008 | 99.2K | — | 62.0K |
| Cox JohnEVP Pharmaceutical Oper & Tech · 73 transactions | — | 39.0Kas of Apr 2016 | 127.3K | — | 78.8K |
| Papadopoulos SteliosDirector · 26 transactions | — | 38.3K†as of Jun 2022 | 77.0K | 10.0K | 48.7K |
| Dorsa CarolineDirector · 36 transactions | — | 31.0Kas of Jun 2025 | 65.8K | 2.8K | 37.6K |
| Adelman Burt AEVP, Portfolio Strategy · 42 transactions | — | 29.7K†as of Feb 2008 | 419.3K | — | 395.5K |
| Hamm Robert AChief Operating Officer · 91 transactions | — | 28.6Kas of Apr 2010 | 270.0K | — | 222.6K |
| Rowinsky Eric KDirector · 32 transactions | — | 25.8K | 63.7K | 455 | 38.3K |
| Dunn John MichaelEVP, New Ventures · 75 transactions | — | 24.8Kas of Feb 2009 | 173.1K | — | 132.3K |
| McDonnell Michael REVP, Chief Financial Officer · 32 transactions | — | 24.3Kas of Feb 2025 | 44.0K | — | — |
| Wiggins Mark CEVP Corp. and Bus. Dev. · 132 transactions | — | 23.5K†as of Sep 2008 | 470.0K | — | 458.3K |
| Gregory GingerEVP, Human Resources · 66 transactions | — | 22.4K | 48.2K | — | 8.3K |
| Kowolenko MichaelSVP, Pharm Ops & Technology · 20 transactions | — | 21.6Kas of Jul 2007 | 66.3K | — | 45.0K |
| Viehbacher ChristopherPresident and CEO, Director · 8 transactions | — | 21.1K | 40.5K | — | — |
| Pangia Robert WDirector · 124 transactions | — | 20.6K†as of Dec 2020 | 179.9K | — | 159.4K |
| Lytton MichaelEVP Corporate & Business Devel · 3 transactions | — | 20.0Kas of Mar 2010 | 10.5K | — | — |
| Murphy NicoleHead of Pharm Ops and Tech · 45 transactions | — | 19.6K | 27.7K | 3 | — |
| Kellogg Peter NEVP, Finance and CFO · 15 transactions | — | 19.0Kas of Mar 2007 | 67.5K | — | 39.5K |
| Young WilliamDirector · 23 transactions | — | 18.5Kas of Jan 2014 | 125.0K | — | 93.3K |
| Sherwin Stephen ADirector · 49 transactions | — | 15.2K | 64.0K | — | 44.0K |
| Mulligan RichardDirector · 28 transactions | — | 15.1Kas of Jun 2022 | 63.9K | — | 48.9K |
| Leaming NancyDirector · 34 transactions | — | 13.8Kas of Jul 2021 | 73.4K | — | 58.3K |
| Pawlicki RaymondSVP, Chief Information Officer · 18 transactions | — | 12.7Kas of Nov 2013 | 32.5K | — | 29.1K |
| Schenk LYNNDirector · 41 transactions | — | 12.1K†as of Jun 2019 | 150.8K | — | 136.6K |
| Williams Douglas EEVP Research & Development · 25 transactions | — | 11.8Kas of Jun 2015 | 39.3K | — | 11.7K |
| Izzar RachidHead of Global Product Strat. · 43 transactions | — | 11.8K | 26.4K | — | 2.2K |
| Mantas Jesus BDirector · 9 transactions | — | 11.3K | 10.4K | 898 | — |
| Ross BruceDirector · 33 transactions | — | 10.9Kas of Jun 2010 | 61.9K | — | 52.0K |
| Clancy Paul JExecutive VP and CFO · 153 transactions | — | 10.8Kas of Apr 2017 | 306.3K | — | 240.0K |
| MacLean Michael FSVP, Chief Accounting Officer · 45 transactions | — | 10.7Kas of Oct 2010 | 40.2K | — | 21.5K |
| Schneier Craig EricEVP, HR, Public Affairs & Comm · 164 transactions | — | 10.7K†as of Mar 2011 | 463.9K | — | 433.5K |
| Hawkins William ADirector · 8 transactions | — | 10.4K | 10.4K | — | — |
| Sandrock AlfredHead of Research & Development · 115 transactions | — | 10.2Kas of Jun 2021 | 80.1K | — | 56.0K |
| Kramer RobinChief Financial Officer · 62 transactions | — | 9.0K | 16.4K | — | — |
| Freire Maria CDirector · 6 transactions | — | 8.8K | 8.8K | — | — |
| Karaboutis AdrianaEVP, Tech, Bus. Sol & Corp Aff · 23 transactions | — | 8.8Kas of Feb 2017 | 15.0K | — | 1.5K |
| Holtzman Steven HEVP Corporate Development · 38 transactions | — | 8.6Kas of Feb 2016 | 40.6K | — | 15.8K |
| Ehlers Michael DEVP, Research and Development · 19 transactions | — | 8.5Kas of Jun 2019 | 14.0K | — | 1.0K |
| Kingsley Stuart AEVP, Global Comm. Operations · 33 transactions | — | 8.5Kas of Feb 2015 | 34.5K | — | 12.8K |
| DiPietro KennethEVP Human Resources · 33 transactions | — | 8.3Kas of Feb 2017 | 25.2K | — | 8.0K |
| Singhal PriyaHead of Development · 56 transactions | — | 8.0K | 27.5K | — | 11.1K |
| Posner Brian SDirector · 40 transactions | — | 8.0Kas of Jun 2022 | 69.2K | — | 60.1K |
| Guindo ChirfiHead of Glob Prod Strat & Com · 24 transactions | — | 7.4Kas of Feb 2022 | 14.1K | — | 3.1K |
| McKenzie PaulEVP Pharmaceutical Oper & Tech · 17 transactions | — | 7.2Kas of Mar 2019 | 10.3K | — | — |
| Langer SusanDirector · 4 transactions | — | 6.6K | 6.2K | — | — |
| Dekkers Marijn EDirector · 3 transactions | — | 6.6Kas of Jun 2009 | 6.6K | — | — |
| Keeney AdamHead of Corporate Development · 12 transactions | — | 6.4K | 9.7K | — | — |
| Keller Thomas FDirector · 13 transactions | — | 6.3K†as of Oct 2007 | 41.5K | — | 48.3K |
| Galdes AlphonseEVP Pharmaceutical Oper & Tech · 17 transactions | — | 6.0K†as of Jan 2022 | 4.6K | — | — |
| Glassberg AlanDirector · 44 transactions | — | 5.6Kas of Jun 2008 | 52.5K | — | 46.9K |
| Best Lawrence CDirector · 3 transactions | — | 5.6Kas of Jun 2008 | 5.6K | — | — |
| Patolawala Monish DDirector · 3 transactions | — | 5.2K | 5.2K | — | — |
| Granata FrancescoEVP Global Commercial Operatio · 7 transactions | — | 5.2Kas of Feb 2012 | 9.5K | — | 2.9K |
| Covino Gregory FVP, Chief Accounting Officer · 36 transactions | — | 4.7Kas of Feb 2018 | 4.7K | — | — |
| Gagnon Robert E.Vice President, Finance · 47 transactions | — | 4.4Kas of Feb 2012 | 10.3K | — | 16.1K |
| Minor LloydDirector · 2 transactions | — | 3.9K | 3.9K | — | — |
| Pangalos Menelas NDirector · 2 transactions | — | 3.9K | 3.9K | — | — |
| Capello Jeffrey DEVP & Chief Financial Officer · 6 transactions | — | 3.7Kas of Feb 2020 | 4.6K | — | — |
| Grogan JaneHead of Research · 10 transactions | — | 3.2K | 6.0K | — | — |
| Artavanis-Tsakonas SpyridonEVP, Chief Scientific Officer · 19 transactions | — | 3.1Kas of Apr 2016 | 6.0K | — | 2.0K |
| Koppel AdamEVP, Strategy and Bus. Dev. · 8 transactions | — | 2.4Kas of Jun 2016 | 4.3K | — | 657 |
| Jones William D /CA/Director · 2 transactions | — | 2.1Kas of Jun 2022 | 2.1K | — | — |
| Godbout SeanChief Accounting Officer · 10 transactions | — | 1.4K | 1.3K | — | — |
| Good Mary LDirector · 10 transactions | — | 1.3Kas of May 2007 | 25.8K | — | 24.5K |
| Karp DanielEVP, Corporate Development · 4 transactions | — | 1.2Kas of Feb 2020 | 1.2K | — | — |